Carol Hamilton, MD, MHS

Director, Scientific Affairs

Areas of expertise

  • Tuberculosis prevention, care and treatment, research and programs
  • Infectious diseases
  • TB-HIV co-infection research and programs
  • Vaccine-preventable diseases
  • Neglected tropical diseases
  • Global public health and development

Projects & Resources

Published Research

  • Developing a framework for evaluating ethical outcomes of good participatory practices in TB clinical drug trials
    MacQueen KM, Eley NT, Frick M, Mingote LR, Chou A, Seidel SS, Hannah S, Hamilton C
    J Empir Res Hum Res Ethics 2016 Jul; 11(3): 203-13. [Journal Impact Factor: 1.146]

    With the growing acceptance of community engagement and participatory strategies in clinical research, evaluation of the benefits and burdens are needed. Working with global tuberculosis (TB) stakeholders, the authors developed a theory of change evaluation framework for the Good Participatory Practice Guidelines for TB Drug Trials. The framework is a first step in systematically evaluating participatory research in clinical trials.

Explore More Related to Carol Hamilton, MD, MHS